Overview
Andrew Bongiovanni is a primary care provider, practicing in Internal Medicine in Broomall, Pennsylvania.
Dr. Bongiovanni is highly rated in 1 condition, according to our data. His clinical expertise encompasses Hyperlipidemia Type 3, Neuroendocrine Tumor, High Cholesterol, and Hypertension.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
Locations
1991 Sproul Rd Ste 450, Broomall, PA 19008
Temple University Hospital
Henry Parkman is an Internal Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Parkman is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Gastroparesis, Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Gastrectomy, and Endoscopy.
Penn Endocrine And Oncologic Surgery Perelman 3RD Floor
David Metz is an Internal Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Metz is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Zollinger-Ellison Syndrome, Pancreatic Islet Cell Tumor, Endoscopy, and Colonoscopy.
Penn Renal Electrolyte And Hypertension Perelman
Lawrence Holzman is a primary care provider, practicing in Internal Medicine in Philadelphia, Pennsylvania. Dr. Holzman is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Minimal Change Disease, Nephrotic Syndrome, Glomerulonephritis, Focal Segmental Glomerulosclerosis, and Kidney Transplant. Dr. Holzman is board certified in Internal Medicine, 1987. Dr. Holzman is currently accepting new patients.
Frequently Asked Questions about Dr. Andrew Bongiovanni
How do I make an appointment with Dr. Andrew Bongiovanni?
You can book an appointment with Dr. Andrew Bongiovanni by calling their office at 484-421-3001. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Andrew Bongiovanni a top-rated expert for Hyperlipidemia Type 3?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew Bongiovanni is classified as an Advanced expert for Hyperlipidemia Type 3, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Andrew Bongiovanni specialize in?
While Dr. Andrew Bongiovanni is a Internal Medicine, they have specific expertise in Hyperlipidemia Type 3, Neuroendocrine Tumor, and High Cholesterol. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Andrew Bongiovanni accept my insurance?
Dr. Andrew Bongiovanni accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 484-421-3001 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hyperlipidemia Type 3Dr. Bongiovanni isAdvanced. Learn about Hyperlipidemia Type 3.
- Experienced
- AnemiaDr. Bongiovanni isExperienced. Learn about Anemia.
- ArachnodactylyDr. Bongiovanni isExperienced. Learn about Arachnodactyly.
- AtherosclerosisDr. Bongiovanni isExperienced. Learn about Atherosclerosis.
- Athlete's FootDr. Bongiovanni isExperienced. Learn about Athlete's Foot.
- Chronic CoughDr. Bongiovanni isExperienced. Learn about Chronic Cough.
- Chronic Myelogenous Leukemia (CML)Dr. Bongiovanni isExperienced. Learn about Chronic Myelogenous Leukemia (CML).